Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Fightback is a beer and cider brand on a mission to save music venues with support from across the live music industry. The company claims that every pint sold contributes to Music Venue Trust (MVT), a UK-registered charity, which acts to protect, secure, and improve Grassroots Music Venues. It argues that it has sold 10,000 pints and 10,000 cans in 61 venues before the COVID-19 lockdown. Fightback asserts that it has agreed on a new national distribution deal to make the brand more accessible amidst the lockdown. It intends to supply 900+ venues affiliated with MVT when venues reopen. Fightback will use the investment to roll out beer and cider to help secure the long-term future of the venues that ensure that the music culture is kept alive.
days to go:
Expired
investment:
£52,596
Bambooloo is a sustainable consumer products company that creates, manufactures, and sells earth-friendly, modern brands. It has set up its base of operations in Singapore and is endeavouring to enter the UK market soon. Bambooloo launched to high acclaim both online and offline in Singapore with its 100% plastic free packaging product line. It is now on the verge of launching its other product lines; The Nurturing Co-brand focused on care and cleaning products with zero one time use plastics; and Wipeless, an environmentally focused bidet brand. Bambooloo argues that the global hygiene paper sector alone is valued at over $84 billion per year. It aims to be a segment leader in this sector. Bambooloo was the inaugural winner of the Sustainable Business Award Winner 2019. The company will use the investment to establish a beachhead business in the UK, hire internal and external teams for marketing, and set up its website for procuring more orders.
days to go:
Expired
investment:
£187,013
Clinical Net is a health-tech firm focused on revolutionizing access to innovative clinical trials. Their AI platform swiftly connects patients with suitable trials, addressing the challenge of low participation rates and delays that hinder pharmaceutical research. With over 69,000 trials globally, their solution aims to streamline the cumbersome and time-consuming process of trial matching, making it more efficient and accessible within 5 minutes. This innovative approach targets the $3.73 billion patient recruitment market while ensuring individuals have easier access to groundbreaking treatments.
days to go:
Expired
investment:
£136,827
BuyMeOnce is an online marketplace selling incredibly sustainable and long-lasting products. It is a novel mixture of review site and web-shop, using its criteria of craftsmanship, best materials, aftercare, ethics and independent reviews. BuyMeOnce's total addressable market is £404 billion across the UK and the US with a projected attainable market of £21 billion. By highlighting on durability and sustainability, BuyMeOnce is helping brands compete on quality. Till date, it has found and approved 2,000+ products that meet its standards. Its business model enables it to be unbiased where brands can't pay to be on BuyMeOnce. Furthermore, it is on a mission to reform throwaway consumerism and to reduce pollution, waste and CO2 emissions.
days to go:
Expired
investment:
£545,540
Jewelstreet is on a mission to connect jewellery designers to buyers from all over world. They have 570 designers and brands with over 20,000 unique pieces of jewellery. The funding will be used for marketing to further the profile of Jewelstreet and increase their customer base.
days to go:
Expired
investment:
£251,770
The Stem is an online garden centre aiming to become a leading digital brand in the £7.5 billion per annum UK garden retail market. It is on a mission to make plants and gardening more accessible than ever and in the most sustainable way possible. The company has made over 7,880 deliveries to 6,800 customers across London since launching its new website in March 2020. The Stem has a 97% Net Promoter Score (NPS) and 4.97/5* customer rating. The company will use the investment to expand its product categories and catchment area, build its team and brand, develop its content platform and supply chain.
days to go:
Expired
investment:
£550,008
